Enochian Biosciences
is a true platform for personalized precision medicine drug substance off the shelf ready to pulse with any tumor type infectious disease agent multiple flexibilities in manufacturing final drug products including future universal cancer antigens for true off the shelf products can be combined with other cancer therapies chemotherapy immune inhibitors exploring other indications in oncology infectious diseases | Enochian Biosciences
Company
Deck Type
Sector
Industry
Deck date
January 2024
Slide
8 of 28
Related slides by other companies
BioNTech
Results
August 2021
disease horizon expanding the application spectrum of our technology grow mature novel technologies across oncology infectious diseases and beyond | BioNTech
Immatics
Investor Presentation
November 2023
true cancer targets matching right | Immatics
Invitae
Results
November 2023
enhanced personalized cancer monitoring | Invitae
AbCellera
Investor Presentation
November 2023
drug development has three steps | AbCellera
Other recent decks by Enochian Biosciences
See all presentations (3 decks)
Results
August 2023
Investor Presentation
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io